Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REPAIR-AMI
NCT00279175Phase 3Completed
- Start
- Apr 2004
- Primary completion
- Oct 2005
- Modality
- Stem Cell Therapies, Adoptive Cell Transfer
- Countries
- 2
01
Overview
Phase 3, randomised, double-blind trial of autologous bone marrow-derived progenitor cells in acute myocardial infarction (AMI) (2 arms). Primary endpoint: Change in global left ventricular ejection fraction at 4 months. Started Apr 2004; status: completed.
02
Drugs
autologous bone marrow-derived progenitor cells
03
Conditions
acute myocardial infarction (AMI)
Beyond the preview
Go deeper on NCT00279175.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00279175.